Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Screening for new compounds with antiherpes activity.

B Alarcón, J C Lacal, J M Fernández-Sousa

    Antiviral Research
    |October 1, 1984
    PubMed
    Summary

    Several compounds demonstrated significant antiherpes activity against herpes simplex virus type 1. Actinobolin, amicetin, and tetracenomycin C also showed efficacy against other viral infections, highlighting their broad antiviral potential.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Plitidepsin as a successful rescue treatment for prolonged viral SARS-CoV-2 replication in a patient with previous anti-CD20 monoclonal antibody-mediated B cell depletion and chronic lymphocytic leukemia.

    Journal of hematology & oncology·2022
    Same author

    Plitidepsin for the management of a cancer patient infected with SARS-CoV-2 while receiving chemotherapy.

    Annals of oncology : official journal of the European Society for Medical Oncology·2021
    Same author

    A window of opportunity for cooperativity in the T Cell Receptor.

    Nature communications·2018
    Same author

    Amyophatic dermatomyositis presenting as a flagellated skin eruption with positive MDA5 antibodies and thyroid cancer: a real association?

    Clinical and experimental dermatology·2015
    Same author

    Effects of eccentric overload bout on change of direction and performance in soccer players.

    International journal of sports medicine·2014
    Same author

    A new family of choline kinase inhibitors with antiproliferative and antitumor activity derived from natural products.

    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2014

    Area of Science:

    • Virology
    • Microbiology
    • Pharmacology

    Background:

    • Herpes simplex virus type 1 (HSV-1) infections pose a significant public health challenge.
    • Development of novel antiviral agents is crucial for managing HSV-1 and related viral infections.
    • Existing antiviral therapies have limitations, necessitating the search for new compounds.

    Purpose of the Study:

    • To evaluate the antiherpes activity of various compounds against herpes simplex virus type 1.
    • To compare the efficacy of newly identified antiherpes compounds with previously known agents.
    • To investigate the broader antiviral spectrum of promising candidate compounds.

    Main Methods:

    • HeLa cell monolayers were infected with herpes simplex virus type 1.
    • Compounds including actinobolin, amicetin, carrageenan, laspartomycin, megalomycin C, pleuromutilin, suramin, and tetracenomycin C were tested for their protective effects.
    • The antiviral activity of selected compounds was assessed and compared to established antiherpes agents.

    Main Results:

    • Actinobolin, amicetin, carrageenan, laspartomycin, megalomycin C, pleuromutilin, suramin, and tetracenomycin C exhibited significant protection of HeLa cells against HSV-1 infection.
    • Actinobolin, amicetin, and tetracenomycin C demonstrated activity against viruses beyond HSV-1, indicating a broader antiviral spectrum.
    • The efficacy of these compounds was comparable to or showed promise relative to previously described antiherpes agents.

    Conclusions:

    • Several tested compounds, notably actinobolin, amicetin, and tetracenomycin C, possess significant antiherpes simplex virus type 1 activity.
    • Actinobolin, amicetin, and tetracenomycin C display potential as broad-spectrum antiviral agents.
    • These findings warrant further investigation into the therapeutic potential of these compounds for viral infections.

    Related Experiment Videos